BioRestorative Therapies, Inc. (BRTX)
1.50
-0.12
(-7.41%)
USD |
NASDAQ |
Oct 26, 16:00
1.49
-0.01
(-0.67%)
After-Hours: 18:06
BioRestorative Therapies Net Income (TTM) : -11.06M for March 31, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -11.06M |
| December 31, 2025 | -14.24M |
| September 30, 2025 | -12.67M |
| June 30, 2025 | -10.72M |
| March 31, 2025 | -12.10M |
| December 31, 2024 | -8.979M |
| September 30, 2024 | -6.171M |
| June 30, 2024 | -0.311M |
| March 31, 2024 | -1.992M |
| December 31, 2023 | -6.941M |
| September 30, 2023 | -12.46M |
| June 30, 2023 | -21.89M |
| March 31, 2023 | -20.85M |
| December 31, 2022 | -18.49M |
| September 30, 2022 | -34.55M |
| June 30, 2022 | -34.08M |
| March 31, 2022 | -33.47M |
| December 31, 2021 | -44.30M |
| September 30, 2021 | -29.66M |
| June 30, 2021 | -26.31M |
| March 31, 2021 | -19.38M |
| December 31, 2020 | -11.27M |
| September 30, 2020 | -7.062M |
| June 30, 2020 | -11.28M |
| March 31, 2020 | -18.32M |
| Date | Value |
|---|---|
| December 31, 2019 | -14.65M |
| September 30, 2019 | -16.67M |
| June 30, 2019 | -14.54M |
| March 31, 2019 | -13.89M |
| December 31, 2018 | -12.52M |
| September 30, 2018 | -10.81M |
| June 30, 2018 | -9.934M |
| March 31, 2018 | -9.167M |
| December 31, 2017 | -9.445M |
| September 30, 2017 | -9.642M |
| June 30, 2017 | -9.424M |
| March 31, 2017 | -8.935M |
| December 31, 2016 | -8.636M |
| September 30, 2016 | -9.699M |
| June 30, 2016 | -9.489M |
| March 31, 2016 | -8.651M |
| December 31, 2015 | -7.924M |
| September 30, 2015 | -6.289M |
| June 30, 2015 | -5.765M |
| March 31, 2015 | -5.678M |
| December 31, 2014 | -5.588M |
| September 30, 2014 | -5.734M |
| June 30, 2014 | -5.937M |
| March 31, 2014 | -5.855M |
| December 31, 2013 | -5.751M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Myriad Genetics, Inc. | -112.60M |
| CareDx, Inc. | 111.01M |
| Natera, Inc. | -192.35M |
| Exagen, Inc. | -18.92M |
| Sera Prognostics, Inc. | -33.23M |